One of the key factors behind IVI’s success rates - up to 23% higher than the average - is their commitment to personalized diagnostics tailored to each patient’s specific needs. To maximize the chances of pregnancy, they offer PGT-A (Preimplantation Genetic Testing forAneuploidy). This genetic test identifies chromosomal and genetic abnormalities in embryosbefore they are …
One of the key factors behind IVI’s success rates - up to 23% higher than the average - is their commitment to personalized diagnostics tailored to each patient’s specific needs.
To maximize the chances of pregnancy, they offer PGT-A (Preimplantation Genetic Testing for
Aneuploidy). This genetic test identifies chromosomal and genetic abnormalities in embryos
before they are transferred to the patient’s uterus.
Unlike other tests, IVI’s PGT-A combines the benefits of two types of genetic analysis:
– Using an advanced sequencing method, they evaluate DNA quantity at thousands
of points across each chromosome.
– They also assess variations in the DNA sequence.
With the information provided by both approaches, they deliver a high-value service that
enables them to detect embryos with ploidy alterations—such as triploid embryos (three copies
of each chromosome) or haploid embryos (one copy of each chromosome).
Pioneers
IVI’s PGT-A is a pioneer in the field and is recognized as a benchmark in assisted
reproduction. The cutting-edge technology they use provides a high degree of accuracy, which
means more euploid embryos (with the correct number of chromosomes) are identified
correctly. This reduces both false positive and false negative rates—leading to the ultimate
goal shared by patients and fertility specialists: transferring the most viable embryos and
reducing the risk of miscarriage. In short, their goal is to increase the chances of achieving
pregnancy.
Advantages of PGT-A
IVI’s PGT-A offers several advantages over other options:
– The test does not affect embryo development.
– Helps achieve pregnancy in less time.
– Improves the ability to correctly distinguish between euploid and aneuploid embryos,
increasing the number of viable embryos available for transfer and reducing the risk
of chromosomal abnormalities.
– Enhances analytical capacity, delivering the best results in terms of minimizing false
positives and false negatives.
– Supports single embryo transfer (SET), reducing risks for both mother and babies.
– Prevents the preservation of non-viable embryos.
– Lowers miscarriage rates.
– The test is highly versatile and can be easily combined with other genetic analyses
(e.g., PGT-M, PGT-SR, etc.).
In terms of detection capacity, IVI’s PGT-A allows for the identification of:
– Whole chromosome aneuploidy and segmental aneuploidies
– Ploidy abnormalities, such as haploidy and triploidy
– Contamination
Who is PGT-A for?
For certain patient profiles—and always following a complete fertility assessment—IVF
Genetic is the most effective option for achieving a successful pregnancy. This treatment
combines IVF with PGT-A and is especially recommended for:
• Patients over 35 years old
• Women who have undergone two or more assisted reproduction cycles without achieving
pregnancy
• Women who have experienced two or more unexplained miscarriages
• Women with a previous pregnancy involving chromosomal abnormalities, particularly during
ART cycles
• Couples where the male partner has sperm with meiotic abnormalities or a low sperm count
Find your nearest IVI clinic here to discuss whether PGT-A would be suitable for you – Clinic Finder
